Artera

Artera has raised a total of $110 million across two funding rounds, including a $20 million round in February 2024. Founded in 2021 and headquartered in Los Altos, California, the company employs 101–250 people and specializes in AI-based predictive and prognostic cancer tests, primarily for prostate cancer. Key investors include Prosperity7 Ventures, EDBI, and Trium Ventures. Artera’s AI platform combines digital pathology and clinical data to personalize treatment, with international expansion and further funding anticipated to scale its precision oncology solutions globally.